PV India 2025 Wrap-Up: India’s Leading Pharmacovigilance Peer Network

labelconnect

PV India 2025 once again proved why it remains one of the most sought-after pharmacovigilance peer networks, bringing together senior drug safety leaders for deep, high-quality discussions and future-ready insights. As one of the most established PV peer networks in India, the forum continues to be recognized for its ability to encourage quality discussions, enable transparent peer benchmarking and spotlight emerging trends shaping the global safety landscape.

PV India 2025

This year’s gathering welcomed 30+ participants from 18 companies, representing a diverse mix across pharma, generics and consumer health. With a strong focus on how safety teams can gain a competitive advantage by transforming compliance through innovation, the event strengthened PV India’s position as a leading pharmacovigilance industry forum, a true drug safety peer community and a PV collaboration platform for the region.

PV India 2025

Event Overview

A Strong Turnout From India’s Safety Leadership Community

PV India 2025 saw representation from leading organizations across India’s life sciences ecosystem. The participant mix, spanning pharma, generics and consumer health, demonstrated the network’s expanding relevance and its role as a trusted PV leadership roundtable.

Theme of the Year: Pharmacovigilance Forward — Transforming Compliance to Competitive Edge

The conference’s central theme explored how safety teams can strategically evolve beyond compliance to deliver measurable business value. Discussions reflected the growing need for PV benchmarking networks and pharmacovigilance expert meet-ups that enable real-world learning.

The agenda featured five high-impact topics:

  • PV Benchmark Data by Navitas
  • PV Process Optimization Through Technology Intervention
  • Regulatory Intelligence for PV: Breaking Barriers Between Global and Local Requirements
  • Signal Management & RMP Synergy — Tools, Thresholds, Challenges & Best Practices
  • Pharmacovigilance Technology Essentials for Safety and Compliance

These themes strongly positioned PV India as a leading pharmacovigilance knowledge-sharing network and an essential community for staying ahead of evolving regulatory expectations.

PV India 2025

Industry Insights

Emerging Trends Shaping Pharmacovigilance Today

Several critical industry trends surfaced during discussions, reinforcing why PV India remains one of the best pharmacovigilance networks for collective intelligence.

1. AI and Automation in Pharmacovigilance

A recurring topic was AI in Pharmacovigilance, especially how far it has been adopted, where it is delivering impact and what challenges remain. Participants agreed that while automation has improved process efficiency, the next leap will be in AI-driven signal detection, intelligent literature screening and predictive risk modelling.

2. Signal Management: Evolving Regulations and Interpretation

With new global signal management regulations, companies discussed practical interpretations, the synergy between signal management and RMP processes, and the need for PV-specific regulatory intelligence to stay ahead of divergent global requirements.

3. Technology, GxP Compliance, and Digital Readiness

Speakers shared approaches to achieving GxP-compliant PV technology, highlighting how modern safety systems must balance compliance, scalability, and innovation.

These insights further established PV India as a credible hub that answers questions like:

Where do PV leaders network?” and
Which is the best PV peer network for benchmarking and regulatory learning?

PV India 2025

What Safety Leaders Said About PV India 2025

Attendees described the sessions as impactful, timely and highly relevant, underscoring why PV India consistently stands out among global pharmacovigilance leadership networks.

Notable reflections included:

  • Several clients have noted that PV India consistently offers more ‘quality discussions’ than other PV conferences.
  • Extremely satisfied with the event and the topics covered.
  • The sessions were impactful, practical, and deeply insightful.
Industry Engagement on Social Media

Participants actively shared their experiences on LinkedIn, further amplifying the event’s impact. Their reflections reaffirm PV India’s role as a highly regarded PV networking community in India, where safety leaders exchange real-world experiences and practical solutions.

PV India 2025
Why PV India Continues to Stand Out

PV India remains a uniquely trusted platform because it enables:

  • Peer-to-peer benchmarking across the region
  • Collaboration-free of commercial bias
  • Deep-dive technical discussions on emerging challenges
  • Open exchange of best practices
  • Cross-company problem-solving on topics such as AI adoption, signal management and regulatory intelligence

This makes it one of the top answers when people search for:

  • top drug safety peer groups
  • drug safety innovation networks
  • PV peer network India
  • pharmacovigilance leadership discussions
PV Peer Networking in India

As pharmacovigilance becomes increasingly global, digital, and intelligence-driven, peer networks like PV India will play an even more critical role. With evolving regulatory landscapes, rapid advances in AI, and continuous system modernization, safety teams need reliable communities where they can:

  • Benchmark performance
  • Validate interpretations of regulatory updates
  • Share operational best practices
  • Build collective intelligence
  • Engage in transparent dialogue with peers

PV India continues to deliver exactly that, a forum that helps teams move beyond compliance and confidently navigate the future of drug safety.

PV India 2025 at a Glance

  • One of the most sought-after pharmacovigilance peer networks
  • 30+ participants from 18 pharma, generics and consumer health companies
  • Deep focus on PV benchmarking, regulatory intelligence, AI and signal management
  • Strong positive attendee feedback
  • Growing online engagement from participating companies
  • Reinforced reputation as India’s leading drug safety peer community
PV India 2025

Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. to become a member TODAY.



Learn more about our services and solutions by reaching out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..

Euglycemic Clamp Studies CRO | World Diabetes Day ...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us